PHARMACOKINETIC AND ENDOCRINOLOGIC PARAMETERS OF A SLOW-RELEASE DEPOT PREPARATION OF THE GNRH ANALOG ICI 118630 (ZOLADEX) COMPARED WITH A SUBCUTANEOUS BOLUS AND CONTINUOUS SUBCUTANEOUS INFUSION OF THE SAME DRUG IN PATIENTS WITH PROSTATIC-CANCERP

被引:33
作者
PERREN, TJ
CLAYTON, RN
BLACKLEDGE, G
BAILEY, LC
HOLDER, G
LYNCH, SS
ARKELL, DG
COTTAM, J
FARRAR, D
YOUNG, CH
机构
[1] UNIV BIRMINGHAM, DEPT MED, W MIDLANDS CANC RES CAMPAIGN CLIN TRIALS UNIT, BIRMINGHAM B15 2TH, W MIDLANDS, ENGLAND
[2] UNIV BIRMINGHAM, DEPT MED, BIRMINGHAM B15 2TH, W MIDLANDS, ENGLAND
[3] WOMENS HOSP, DEPT CLIN ENDOCRINOL, BIRMINGHAM, ENGLAND
[4] DUDLEY RD HOSP, BIRMINGHAM B18 7QH, W MIDLANDS, ENGLAND
[5] SELLY OAK HOSP, DEPT UROL, BIRMINGHAM, ENGLAND
关键词
D O I
10.1007/BF00253061
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:39 / 43
页数:5
相关论文
共 15 条
[1]  
AHMED SR, 1983, LANCET, V2, P415
[2]   ADVANCED-CARCINOMA OF THE PROSTATE - TREATMENT WITH A GONADOTROPIN-RELEASING HORMONE AGONIST [J].
ALLEN, JM ;
OSHEA, JP ;
MASHITER, K ;
WILLIAMS, G ;
BLOOM, SR .
BMJ-BRITISH MEDICAL JOURNAL, 1983, 286 (6378) :1607-1609
[3]   SUSTAINED SUPPRESSION OF TESTOSTERONE PRODUCTION BY THE LUTEINIZING-HORMONE RELEASING-HORMONE AGONIST BUSERELIN IN PATIENTS WITH ADVANCED PROSTATE CARCINOMA - A NEW THERAPEUTIC APPROACH [J].
BORGMANN, V ;
HARDT, W ;
SCHMIDTGOLLWITZER, M ;
ADENAUER, H ;
NAGEL, R .
LANCET, 1982, 1 (8281) :1097-1099
[4]  
CLAYTON RN, 1984, Q J MED, V53, P17
[5]   A RADIOIMMUNOASSAY FOR GNRH AGONIST ANALOG IN SERUM OF PATIENTS WITH PROSTATE-CANCER TREATED WITH D-SER (TBU)6AZA GLY10 GNRH [J].
CLAYTON, RN ;
BAILEY, LC ;
COTTAM, J ;
ARKELL, D ;
PERREN, TJ ;
BLACKLEDGE, GRP .
CLINICAL ENDOCRINOLOGY, 1985, 22 (04) :453-462
[6]  
GARNICK MB, 1984, NEW ENGL J MED, V311, P1281
[7]  
KAHAN A, 1984, LANCET, V1, P971
[8]   FAILURE OF LONG-TERM LUTEINIZING-HORMONE RELEASING HORMONE-TREATMENT FOR PROSTATIC-CANCER TO SUPPRESS SERUM LUTEINIZING-HORMONE AND TESTOSTERONE [J].
KERLE, D ;
WILLIAMS, G ;
WARE, H ;
BLOOM, SR .
BRITISH MEDICAL JOURNAL, 1984, 289 (6443) :468-469
[9]   SIMULTANEOUS ADMINISTRATION OF PURE ANTIANDROGENS, A COMBINATION NECESSARY FOR THE USE OF LUTEINIZING-HORMONE-RELEASING HORMONE AGONISTS IN THE TREATMENT OF PROSTATE-CANCER [J].
LABRIE, F ;
DUPONT, A ;
BELANGER, A ;
EMOND, J ;
MONFETTE, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (12) :3861-3863
[10]   LONG-TERM EFFECTS OF ADMINISTRATION OF A GONADOTROPIN-RELEASING HORMONE SUPERAGONIST ANALOG IN MEN WITH PROSTATIC-CARCINOMA [J].
SANTEN, RJ ;
DEMERS, LM ;
MAX, DT ;
SMITH, J ;
STEIN, BS ;
GLODE, LM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 58 (02) :397-400